+987.9%
MRNA vs CLX
-6.5%
+994.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CLX | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +5.7% | +7.4% | +10.3% |
| 7D | +20.6% | +14.2% | +6.5% | +13.6% |
| 30D | +27.1% | +22.7% | +4.5% | +14.7% |
| 3M | +353.4% | -2.8% | +356.1% | +372.8% |
| 6M | +446.3% | +17.7% | +428.6% | +462.9% |
| YTD | +776.2% | +3.3% | +772.8% | +803.1% |
| 1Y | +987.9% | -5.6% | +993.5% | +1,073.8% |
| All | +987.9% | -6.5% | +994.5% | +1,073.8% |
Cumulative growth
Daily Returns
Daily percentage return beside CLX.
Daily Out/Under-Performance
Portfolio return minus CLX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CLX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CLX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling